Hugo Osório
ORCID: 0000-0002-6362-8255
· 1 paper in corpus
2021
Bladder cancer (BC) management demands the introduction of novel molecular targets for precision medicine. Cell surface glycoprotein CD44 has been widely studied as a potential biomarker of BC aggressiveness and cancer stem cells. However, …